BOCA RATON, Fla.--(BUSINESS WIRE)--Nov. 11, 2015-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced Chief Executive Officer Robert G. Finizio will provide an overview of the company at the Stifel 2015 Healthcare Conference on November 17^th at The New York Palace Hotel in New York. The presentation is scheduled to begin at 10:15 a.m. EST.

Details for the presentation and webcast are:

Shortly after completion of the webcast, replays will be available for at least 30 days on the company's website, www.therapeuticsmd.com, in the “Investor” section.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD^® and BocaGreenMD^® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151111005097/en/

Source: TherapeuticsMD, Inc.

TherapeuticsMD, Inc.
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com